1. What Sanofi might buy with its Regeneron windfall — Gilead pens $2B Arcus pact for immuno-oncology targets — FDA approves BMS Opdivo + Yervoy combo for first-line on certain types of NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Merck Lab Personnel

Anonymous board for Merck scientists and lab personnel.


Sort By:
Title
Replies Views
Last Message
  1. MSBioGirl_26
    Replies:
    3
    Views:
    2,544
  2. Anonymous
    Replies:
    2
    Views:
    3,203
  3. Anonymous
    Replies:
    3
    Views:
    3,887
  4. Anonymous
    Replies:
    3
    Views:
    3,495
  5. Anonymous
    Replies:
    1
    Views:
    3,632
  6. Anonymous
    Replies:
    4
    Views:
    5,349
  7. Anonymous
    Replies:
    0
    Views:
    3,895

Thread Display Options

Loading...